Search Results

Your search for Ellin Berman, MD matches 2 pages

Showing 1 - 2

By The ASCO Post Staff / NCCN 2018 Annual Conference

Ellin Berman, MD, on CML: Disease Management During Pregnancy

Ellin Berman, MD, of Memorial Sloan Kettering Cancer Center, discusses the effects of TKI therapy on fetal development, its impact on pregnancy outcomes, and how to develop an effective treatment plan.

leukemia

By Ellin Berman, MD / December 25, 2017

Bosutinib for First-Line Use in Chronic Myeloid Leukemia: Is Three a Crowd?

BOSUTINIB ( BOSULIF) is the latest tyrosine kinase inhibitor that has shown a superior molecular response profile when compared with imatinib.1,2 An orally available dual SRC/ABL1 inhibitor, the drug was shown in preclinical studies to have a potent inhibitory activity against BCR-ABL1 and minimal ...

Apr

Today In Oncology

Search Results

Your search for Ellin Berman, MD matches 2 pages

Ellin Berman, MD, on CML: Disease Management During Pregnancy

Bosutinib for First-Line Use in Chronic Myeloid Leukemia: Is Three a Crowd?

FDA Approves Lu-177 Dotatate for Pediatric Patients With GEP-NETs

AI Model May Help Predict Treatment Responses Select Most Effective Cancer Therapies in Patients With Cancer

In-Hospital Mortality Among Patients With COVID-19 Infection, With or Without Cancer

Imaging Drug to Assist in Detection of Cancerous Tissue Following Lumpectomy Approved

Potential Protective Effects of Aspirin Against Colorectal Cancer